BioSpace News Archive

As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics today announced the launch of a series of new, innovative mycotoxins analysis products and services for customers globally.

Data to be presented at the 2019 Genitourinary Cancers Symposium

First-Time Data from Pivotal Phase 3 KEYNOTE-426 Trial Showing KEYTRUDA® (pembrolizumab) in Combination with Inlyta® (axitinib) Significantly Improved OS, PFS and ORR Compared to Sunitinib Monotherapy in First-Line Treatment of Advanced Renal Cell Carcinoma

EMD Serono announced that the US Food and Drug Administration has accepted for Priority Review the supplemental Biologics License Application for BAVENCIO® in combination with INLYTA®* for patients with advanced renal cell carcinoma.

iProov, a leading provider of biometric authentication technology and genuine presence assurance, today announces the launch of its Palm Verifier product at Finovate Europe 2019.

The FY19 Defense Appropriation provides $7.5 million (M) to the Department of Defense Autism Research Program (ARP) to provide support for research of exceptional scientific merit and innovation with high impact that focuses on autism spectrum disorders (ASD).

A MANUFACTURER of specialist biomedical testing equipment has launched a free mobile phone app to help clinical engineers performing electrical safety tests in the field.

LOCI, the company known as the first to integrate IP staking on blockchain, is currently developing a registry that will consist of open-source patents, an expansion to its existing search functionality and suite of products that currently allows inventors to conduct research and analysis of their ideas for pennies on the dollar.

Nektar Therapeutics announced that it will webcast an analyst and investor conference call with a urothelial cancer specialist and company management on Friday, February 15, 2019 at 2:00 p.m. Pacific Time

Canada is experiencing an unprecedented change in its population: by 2030, nearly a quarter of Canadians will be 65 or older.